All Stories

  1. Cytocompatibility, fibroblast adhesion and proliferation on surface modified 3D-printed PEEK scaffolds
  2. KCNN3genetic variants rs1218585 and rs1218584 are associated with spontaneous preterm birth in a Portuguese population
  3. Mechanistic Insights of a p53-Targeting Small Molecule
  4. Triazole‐Derived Ruthenium(II) Complexes as Novel Candidates for Cancer Therapy
  5. Synthesis, characterization and biological activity of methotrexate-derived salts in lung cancer cells
  6. Nitroaromatic-based triazene prodrugs to target the hypoxic microenvironment in glioblastoma
  7. Optimization of Antiproliferative Properties of Triimine Copper(II) Complexes
  8. Bringing Hope to Improve Treatment in Pancreatic Ductal Adenocarcinoma—A New Tool for Molecular Profiling of KRAS Mutations in Tumor and Plasma Samples
  9. Evaluation of Biotechnological Active Peptides Secreted by Saccharomyces cerevisiae with Potential Skin Benefits
  10. Structural insights of an LCP protein–LytR–from Streptococcus dysgalactiae subs. dysgalactiae through biophysical and in silico methods
  11. Evaluation of miR-155 silencing using a molecular beacon in human lung adenocarcinoma cell line
  12. Discovery of novel fluorescent azaindoles with cytotoxic action in A2780 ovarian carcinoma cells
  13. Mild hyperthermia via gold nanoparticles and visible light irradiation for enhanced siRNA and ASO delivery in 2D and 3D tumour spheroids
  14. Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ–Bridged Crystal Structure: Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models
  15. Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents
  16. Anti-inflammatory and antiproliferative activity of Helichrysum odoratissimum Sweet. against lung cancer
  17. Assessing the gene silencing potential of AuNP-based approaches on conventional 2D cell culture versus 3D tumor spheroid
  18. Effect of mono- and dinuclear thiosemicarbazone platinacycles in the proliferation of a colorectal carcinoma cell line
  19. Membrane-localized magnetic hyperthermia promotes intracellular delivery of cell-impermeant probes
  20. Exploring the synthesis of aminal guanidine-based molecules: synthesis of cernumidine and analogues, and survey of its anti-inflammatory activity
  21. Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation
  22. Antimicrobial Activity of Manganese(I) Tricarbonyl Complexes Bearing 1,2,3-Triazole Ligands
  23. Tackling Imatinib Resistance via Au‐nanoconjugates using A Cml Resistant Cell Line
  24. Exploring the Multifaceted Potential of a Peptide Fraction Derived from Saccharomyces cerevisiae Metabolism: Antimicrobial, Antioxidant, Antidiabetic, and Anti-Inflammatory Properties
  25. Novel Hydrogel Membranes Based on the Bacterial Polysaccharide FucoPol: Design, Characterization and Biological Properties
  26. In Vitro and In Vivo Biological Activities of Dipicolinate Oxovanadium(IV) Complexes
  27. Su1406 A NOVEL MOLECULAR ASSAY TO EVALUATE KRAS MUTATIONS IN TUMOR AND PLASMA SAMPLES OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA AND THEIR PROGNOSTIC IMPACT: ONE STEP CLOSER TO TRANSLATE KRAS GENOTYPING INTO CLINICAL PRACTICE
  28. Combining the amplification refractory mutation system and high-resolution melting analysis for KRAS mutation detection in clinical samples
  29. Exploring RAB11A Pathway to Hinder Chronic Myeloid Leukemia-Induced Angiogenesis In Vivo
  30. Cell Uptake of Steroid-BODIPY Conjugates and Their Internalization Mechanisms: Cancer Theranostic Dyes
  31. Chitin-Glucan Complex Hydrogels: Physical-Chemical Characterization, Stability, In Vitro Drug Permeation, and Biological Assessment in Primary Cells
  32. Short Lecture 4 “Evaluation of antiproliferative and anti-angiogenic activity of an ethanolic extract of Helichrysum odoratissimum (L.) Sweet against skin cancer”
  33. Antiproliferative Activity of Buddleja saligna (Willd.) against Melanoma and In Vivo Modulation of Angiogenesis
  34. In Vitro and In Vivo Biological Activity of Ruthenium 1,10-Phenanthroline-5,6-dione Arene Complexes
  35. Editorial: Rational drug design of metal complexes for cancer therapy
  36. Assessing in vivo and in vitro biofilm development by Streptococcus dysgalactiae subsp. dysgalactiae using a murine model of catheter-associated biofilm and human keratinocyte cell
  37. Phylogenetic analysis and accessory genome diversity reveal insight into the evolutionary history of Streptococcus dysgalactiae
  38. Endogenous Fluorescent Proteins in the Mucus of an Intertidal Polychaeta: Clues for Biotechnology
  39. Light Triggered Enhancement of Antibiotic Efficacy in Biofilm Elimination Mediated by Gold-Silver Alloy Nanoparticles
  40. A solvent‐free strategy to prepare amorphous salts of folic acid with enhanced solubility and cell permeability
  41. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NNʹO] ligands: Synthesis, characterization, structural investigations and antiproliferative activity
  42. Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment
  43. Boron clusters (ferrabisdicarbollides) shaping the future as radiosensitizers for multimodal (chemo/radio/PBFR) therapy of glioblastoma
  44. Investigation of the influence of chirality and halogen atoms on the anticancer activity of enantiopure palladium(ii) complexes derived from chiral amino-alcohol Schiff bases and 2-picolylamine
  45. Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
  46. Aggregation versus Biological Activity in Gold(I) Complexes. An Unexplored Concept
  47. New Non-Toxic N-alkyl Cholinium-Based Ionic Liquids as Excipients to Improve the Solubility of Poorly Water-Soluble Drugs
  48. Manganese(I) tricarbonyl complexes as potential anticancer agents
  49. Vanadium(IV) Complexes with Methyl-Substituted 8-Hydroxyquinolines: Catalytic Potential in the Oxidation of Hydrocarbons and Alcohols with Peroxides and Biological Activity
  50. N-Heterocyclic Carbene Iron Complexes as Anticancer Agents: In Vitro and In Vivo Biological Studies
  51. Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer
  52. New Insights on Streptococcus dysgalactiae subsp. dysgalactiae Isolates
  53. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2′:6′,2″-terpyridine ligands: From in vitro to in vivo biological properties
  54. Genetic predisposition for aggressive behaviour related with dopamine and serotonin pathways – an overview
  55. The genetic susceptibility linking preterm birth and periodontal disease – a review
  56. Liposomal Nanosystems in Rheumatoid Arthritis
  57. Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury
  58. In Vitro and In Vivo Effect of Palladacycles: Targeting A2780 Ovarian Carcinoma Cells and Modulation of Angiogenesis
  59. Rosa x hybrida extracts with dual actions: Antiproliferative effects against tumour cells and inhibitor of Alzheimer disease
  60. Half-Sandwich Ru(p-cymene) Compounds with Diphosphanes: In Vitro and In Vivo Evaluation As Potential Anticancer Metallodrugs
  61. A Transcriptomic Approach to the Recruitment of Venom Proteins in a Marine Annelid
  62. Specific Antiproliferative Properties of Proteinaceous Toxin Secretions from the Marine Annelid Eulalia sp. onto Ovarian Cancer Cells
  63. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line
  64. Cu(i) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action
  65. Benchtop X-ray fluorescence imaging as a tool to study gold nanoparticle penetration in 3D cancer spheroids
  66. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities
  67. Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol
  68. Hyperthermia Induced by Gold Nanoparticles and Visible Light Photothermy Combined with Chemotherapy to Tackle Doxorubicin Sensitive and Resistant Colorectal Tumor 3D Spheroids
  69. The Intracellular Number of Magnetic Nanoparticles Modulates the Apoptotic Death Pathway after Magnetic Hyperthermia Treatment
  70. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics
  71. A Tale of Two Ends: Repurposing Metallic Compounds from Anti-Tumour Agents to Effective Antibacterial Activity
  72. Nanotheranostics in Gene Therapy
  73. Synthesis of new hetero-arylidene-9(10H)-anthrone derivatives and their biological evaluation
  74. Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol
  75. Fast Prototyping Microfluidics: Integrating Droplet Digital Lamp for Absolute Quantification of Cancer Biomarkers
  76. Gene Therapy in Cancer Treatment: Why Go Nano?
  77. Size-Dependent Biological Activities of Fluorescent Organosilane-Modified Zinc Oxide Nanoparticles
  78. Antiproliferative Activities of Diimine-Based Mixed Ligand Copper(II) Complexes
  79. Improving the Anti-inflammatory Response via Gold Nanoparticle Vectorization of CO-Releasing Molecules
  80. Zn(II) and Co(II) derivatives anchored with scorpionate precursor: Antiproliferative evaluation in human cancer cell lines
  81. New copper(i) complexes selective for prostate cancer cells
  82. Light Irradiation of Gold Nanoparticles Toward Advanced Cancer Therapeutics
  83. Cation-mediated gelation of the fucose-rich polysaccharide FucoPol: preparation and characterization of hydrogel beads and their cytotoxicity assessment
  84. Targeting Cancer Resistance via Multifunctional Gold Nanoparticles
  85. Antiproliferative activity of heterometallic sodium and potassium-dioxidovanadium(V) polymers
  86. Structural characterization and biological properties of silver(I) tris(pyrazolyl)methane sulfonate
  87. Nanotheranostics Targeting the Tumor Microenvironment
  88. Counteracting the effect of leukemia exosomes by antiangiogenic gold nanoparticles
  89. Occurrence of non-toxic bioemulsifiers during polyhydroxyalkanoate production by Pseudomonas strains valorizing crude glycerol by-product
  90. Ionic Liquids and Salts from Ibuprofen as Promising Innovative Formulations of an Old Drug
  91. Structural aspects of a trimetallic CuII derivative: cytotoxicity and anti-proliferative activity on human cancer cell lines
  92. Enhancement of water solubility of poorly water-soluble drugs by new biocompatible N-acetyl amino acid N-alkyl cholinium-based ionic liquids
  93. New lessons from ancient life: marine invertebrates as a source of new drugs
  94. Targeting Tumor Microenvironment for Cancer Therapy
  95. GLUT1 and GLUT3 involvement in anthocyanin gastric transport- Nanobased targeted approach
  96. A new Cu(II)-O-Carvacrotinate complex: Synthesis, characterization and biological activity
  97. Antibody modified gold nanoparticles for fast colorimetric screening of rheumatoid arthritis
  98. Liquid biopsies in myeloid malignancies
  99. Copper(ii) complexes with 2,2′:6′,2′′-terpyridine, 2,6-di(thiazol-2-yl)pyridine and 2,6-di(pyrazin-2-yl)pyridine substituted with quinolines. Synthesis, structure, antiproliferative activity, and catalytic activity in the oxidation of alkane...
  100. First heterobimetallic Cu(i)–dppf complexes designed for anticancer applications: synthesis, structural characterization and cytotoxicity
  101. Platinum(ii) complexes showing high cytotoxicity toward A2780 ovarian carcinoma cells
  102. Nanoparticles as Delivery Systems in Cancer Therapy
  103. A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
  104. RuII(p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo
  105. Front Cover: The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes (Chem. Eur. J. 55/2018)
  106. The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes
  107. The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes
  108. Cover Feature: POxylated Dendrimer-Based Nano-in-Micro Dry Powder Formulations for Inhalation Chemotherapy (ChemistryOpen 10/2018)
  109. A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms
  110. Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells
  111. POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
  112. Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human Breast Cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression
  113. Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
  114. Evaluation of cell toxicity and DNA and protein binding of green synthesized silver nanoparticles
  115. Streptococcus dysgalactiae subsp. dysgalactiae isolated from milk of the bovine udder as emerging pathogens: In vitro and in vivo infection of human cells and zebrafish as biological models
  116. Synthesis, Cytotoxicity Evaluation in Human Cell Lines and in Vitro DNA Interaction of a Hetero‐Arylidene‐9(10H)‐Anthrone
  117. Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells
  118. Multifunctional microfluidic chip for optical nanoprobe based RNA detection – application to Chronic Myeloid Leukemia
  119. EPR and electrochemical interpretation of bispyrazolylacetate anchored Ni(ii) and Mn(ii) complexes: cytotoxicity and anti-proliferative activity towards human cancer cell lines
  120. Important cytotoxic and cytostatic effects of new copper(i)–phosphane compounds with N,N, N,O and N,S bidentate ligands
  121. Spectroscopy, electrochemistry and antiproliferative properties of Au(iii), Pt(ii) and Cu(ii) complexes bearing modified 2,2′:6′,2′′-terpyridine ligands
  122. Synthesis of tetrahydro-1H-indolo[2,3-b]pyrrolo[3,2-c]quinolonesviaintramolecular oxidative ring rearrangement of tetrahydro-β-carbolines and their biological evaluation
  123. Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma
  124. Potentiating angiogenesis arrest in vivo via laser irradiation of peptide functionalised gold nanoparticles
  125. Understanding the response of Desulfovibrio desulfuricans ATCC 27774 to the electron acceptors nitrate and sulfate - biosynthetic costs modulate substrate selection
  126. Development of PLGA dry powder microparticles by supercritical CO 2 -assisted spray-drying for potential vaccine delivery to the lungs
  127. Mixed ligand aroylhydrazone and N-donor heterocyclic Lewis base Cu(II) complexes as potential antiproliferative agents
  128. Photothermal enhancement of chemotherapy in breast cancer by visible irradiation of Gold Nanoparticles
  129. Dinuclear RuII(bipy)2Derivatives: Structural, Biological, and in Vivo Zebrafish Toxicity Evaluation
  130. Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
  131. Smuggling gold nanoparticles across cell types – A new role for exosomes in gene silencing
  132. Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery?
  133. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
  134. Tumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and Therapy
  135. Gold Nanobeacons for Tracking Gene Silencing in Zebrafish
  136. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents
  137. Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy
  138. Copper(ii) complexes of functionalized 2,2′:6′,2′′-terpyridines and 2,6-di(thiazol-2-yl)pyridine: structure, spectroscopy, cytotoxicity and catalytic activity
  139. Gold Nanoparticles in Molecular Diagnostics and Molecular Therapeutics
  140. Current trends in molecular diagnostics of chronic myeloid leukemia
  141. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses
  142. Peptide-coated gold nanoparticles for modulation of angiogenesis in vivo
  143. Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes
  144. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT
  145. Infection of human keratinocytes by Streptococcus dysgalactiae subspecies dysgalactiae isolated from milk of the bovine udder
  146. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy
  147. Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology
  148. Water soluble heterometallic potassium-dioxidovanadium(V) complexes as potential antiproliferative agents
  149. Synthesis, characterization, thermal properties and antiproliferative potential of copper(ii) 4′-phenyl-terpyridine compounds
  150. In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex
  151. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos
  152. An affinity triggered MRI nanoprobe for pH-dependent cell labeling
  153. A novel mutation inCEBPAgene in a patient with acute myeloid leukemia
  154. Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
  155. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
  156. Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine
  157. POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50Lowering Capacity
  158. Gold nanoparticle-based theranostics: disease diagnostics and treatment using a single nanomaterial
  159. Covalent coupling of gum arabic onto superparamagnetic iron oxide nanoparticles for MRI cell labeling: physicochemical andin vitrocharacterization
  160. A value-added exopolysaccharide as a coating agent for MRI nanoprobes
  161. MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far
  162. Characterization of the antiproliferative potential and biological targets of a trans ketoimine platinum complex
  163. Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy
  164. Cancer therapy
  165. AuNPs for identification of molecular signatures of resistance
  166. Application of Nanotechnology in Drug Delivery
  167. Di- and tri-organotin(IV) complexes of arylhydrazones of methylene active compounds and their antiproliferative activity
  168. Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
  169. Nanotechnology for Cancer Diagnostics and Therapy – An Update on Novel Molecular Players
  170. Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies
  171. Cobalt Complexes with Pyrazole Ligands as Catalyst Precursors for the Peroxidative Oxidation of Cyclohexane: X‐ray Absorption Spectroscopy Studies and Biological Applications
  172. Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells
  173. Cobalt and Zinc Compounds Bearing 1,10-Phenanthroline-5,6-dione or 1,3,5-Triaza-7-phosphaadamantane Derivatives - Synthesis, Characterization, Cytotoxicity, and Cell Selectivity Studies
  174. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis
  175. Biological targets of new metal compounds
  176. Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib
  177. High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort
  178. Cobalt complexes bearing scorpionate ligands: synthesis, characterization, cytotoxicity and DNA cleavage
  179. Toward a Translational Medicine Approach for Hypertrophic Cardiomyopathy
  180. Development of imatinib and dasatinib resistance: dynamics of expression of drug transportersABCB1, ABCC1, ABCG2, MVP, and SLC22A1
  181. Semantic characterization of hypertrophic cardiomyopathy disease
  182. The RIM101 pathway has a role inSaccharomyces cerevisiaeadaptive response and resistance to propionic acid and other weak acids
  183. An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation
  184. Saccharomyces cerevisiae Multidrug Resistance Transporter Qdr2 Is Implicated in Potassium Uptake, Providing a Physiological Advantage to Quinidine-Stressed Cells
  185. N.P.3 03 Three novel mutations of the myelin Po gene (MPZ) in Portuguese families with CMT1B
  186. The SPI1 Gene, Encoding a Glycosylphosphatidylinositol-Anchored Cell Wall Protein, Plays a Prominent Role in the Development of Yeast Resistance to Lipophilic Weak-Acid Food Preservatives
  187. Early transcriptional response of Saccharomyces cerevisiae to stress imposed by the herbicide 2,4-dichlorophenoxyacetic acid
  188. The YEASTRACT database: a tool for the analysis of transcription regulatory associations in Saccharomyces cerevisiae
  189. Saccharomyces cerevisiae adaptation to weak acids involves the transcription factor Haa1p and Haa1p-regulated genes
  190. A proteome analysis of the yeast response to the herbicide 2,4-dichlorophenoxyacetic acid
  191. Saccharomyces cerevisiae Multidrug Transporter Qdr2p (Yil121wp): Localization and Function as a Quinidine Resistance Determinant
  192. Activation and significance of vacuolar H+-ATPase in Saccharomyces cerevisiae adaptation and resistance to the herbicide 2,4-dichlorophenoxyacetic acid
  193. Adaptation of Saccharomyces cerevisiae to the Herbicide 2,4-Dichlorophenoxyacetic Acid, Mediated by Msn2p- and Msn4p-Regulated Genes: Important Role of SPI1
  194. Transcription patterns ofPMA1andPMA2genes and activity of plasma membrane H+-ATPase inSaccharomyces cerevisiaeduring diauxic growth and stationary phase
  195. The activity of plasma membrane H+-ATPase is strongly stimulated duringSaccharomyces cerevisiaeadaptation to growth under high copper stress, accompanying intracellular acidification
  196. Transcriptional Activation of FLR1 Gene during Saccharomyces cerevisiae Adaptation to Growth with Benomyl: Role of Yap1p and Pdr3p
  197. Glucose does not activate the plasma-membrane-bound H + -ATPase but affects pmaA transcript abundance in Aspergillus nidulans
  198. Modification of plasma membrane lipid order and H + -ATPase activity as part of the response of Saccharomyces cerevisiae to cultivation under mild and high copper stress
  199. A Copper-sensing Transcription Factor Regulates Iron Uptake Genes in Schizosaccharomyces pombe
  200. Comparative effects of Saccharomyces cerevisiae cultivation under copper stress on the activity and kinetic parameters of plasma-membrane-bound H + -ATPases PMA 1 and PMA 2
  201. Activation of the H + -ATPase in the plasma membrane of cells of Saccharomyces cerevisiae grown under mild copper stress